Mycobacterium Tuberculosis Infection and Inflammation: what is Beneficial for the Host and for the Bacterium?

Tuberculosis is still a major health problem in the world. Initial interactions between Mycobacterium tuberculosis and the host mark the pathway of infection and the subsequent host inflammatory response. This inflammatory response is tightly regulated by both the host and the bacterium during different stages of infection. As infection progresses, the initial intense pro-inflammatory response observed is regulated by suppressive mediators balancing inflammation. In this environment, M. tuberculosis battles to survive interfering with the host inflammatory response. In this review we discuss the major effector molecules involved in inflammation in relation to the different stages of M. tuberculosis infection.

[1]  N. Reiling,et al.  Mitogen-activated protein kinases p38 and ERK1/2 regulated control of Mycobacterium avium replication in primary murine macrophages is independent of tumor necrosis factor-α and interleukin-10 , 2011, Innate immunity.

[2]  J. Keane,et al.  IL-10 blocks phagosome maturation in mycobacterium tuberculosis-infected human macrophages. , 2011, American journal of respiratory cell and molecular biology.

[3]  Murugesan V. S. Rajaram,et al.  NOD2 controls the nature of the inflammatory response and subsequent fate of Mycobacterium tuberculosis and M. bovis BCG in human macrophages , 2011, Cellular microbiology.

[4]  J. Turner Growing Old and Immunity to Bacteria , 2011 .

[5]  R. Koup,et al.  Preferential infection and depletion of Mycobacterium tuberculosis–specific CD4 T cells after HIV-1 infection , 2010, The Journal of experimental medicine.

[6]  B. Ryffel,et al.  Limited Role for Lymphotoxin α in the Host Immune Response to Mycobacterium tuberculosis , 2010, The Journal of Immunology.

[7]  R. Sabat IL-10 family of cytokines. , 2010, Cytokine & growth factor reviews.

[8]  M. Braunstein,et al.  Granuloma Formation and Host Defense in Chronic Mycobacterium tuberculosis Infection Requires PYCARD/ASC but Not NLRP3 or Caspase-1 , 2010, PloS one.

[9]  C. Harding,et al.  Mycobacterium tuberculosis and TLR2 Agonists Inhibit Induction of Type I IFN and Class I MHC Antigen Cross Processing by TLR9 , 2010, The Journal of Immunology.

[10]  Seokmann Hong,et al.  IL-12p35 Promotes Antibody-Induced Joint Inflammation by Activating NKT Cells and Suppressing TGF-β , 2010, The Journal of Immunology.

[11]  S. Behar,et al.  Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis , 2010, Nature Immunology.

[12]  Murugesan V. S. Rajaram,et al.  Mycobacterium tuberculosis Activates Human Macrophage Peroxisome Proliferator-Activated Receptor γ Linking Mannose Receptor Recognition to Regulation of Immune Responses , 2010, The Journal of Immunology.

[13]  Gregory M. Frank,et al.  A novel p40-independent function of IL-12p35 is required for progression and maintenance of herpes stromal keratitis. , 2010, Investigative ophthalmology & visual science.

[14]  G. Beamer,et al.  CCL5 participates in early protection against Mycobacterium tuberculosis , 2010, Journal of leukocyte biology.

[15]  G. Bancroft,et al.  Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung , 2010, European journal of immunology.

[16]  S. Akira,et al.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors , 2010, Nature Immunology.

[17]  P. Méndez-Samperio Role of interleukin-12 family cytokines in the cellular response to mycobacterial disease. , 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[18]  C. Harding,et al.  Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors , 2010, Nature Reviews Microbiology.

[19]  Kelly J. Hitchens,et al.  Cutting Edge: Mincle Is Essential for Recognition and Adjuvanticity of the Mycobacterial Cord Factor and its Synthetic Analog Trehalose-Dibehenate , 2010, The Journal of Immunology.

[20]  L. Schlesinger,et al.  Diversity in Mycobacterium tuberculosis mannosylated cell wall determinants impacts adaptation to the host. , 2010, Tuberculosis.

[21]  S. Kaufmann,et al.  A role for IL‐18 in protective immunity against Mycobacterium tuberculosis , 2010, European journal of immunology.

[22]  A. Myers,et al.  Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model. , 2010, Arthritis and rheumatism.

[23]  S. Ehlers DC-SIGN and mannosylated surface structures of Mycobacterium tuberculosis: a deceptive liaison. , 2010, European journal of cell biology.

[24]  M. Netea,et al.  Genomewide association study of leprosy. , 2010, The New England journal of medicine.

[25]  Ying Wang,et al.  Genomewide association study of leprosy. , 2009, The New England journal of medicine.

[26]  S. Akira,et al.  Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle , 2009, The Journal of experimental medicine.

[27]  P. Seeberger,et al.  Critical role of amino acid position 343 of surfactant protein-D in the selective binding of glycolipids from Mycobacterium tuberculosis. , 2009, Glycobiology.

[28]  H. Takata,et al.  Identification of Mycobacterial α-Glucan As a Novel Ligand for DC-SIGN: Involvement of Mycobacterial Capsular Polysaccharides in Host Immune Modulation1 , 2009, The Journal of Immunology.

[29]  D. Vestweber,et al.  A murine DC-SIGN homologue contributes to early host defense against Mycobacterium tuberculosis , 2009, The Journal of experimental medicine.

[30]  G. Sireci,et al.  Tuning inflammation in tuberculosis: the role of decoy receptors. , 2009, Microbes and infection.

[31]  Junghee Kang,et al.  Secretory phospholipase A2 plays an essential role in microglial inflammatory responses to Mycobacterium tuberculosis , 2009, Glia.

[32]  A. Cooper,et al.  Cell-mediated immune responses in tuberculosis. , 2009, Annual review of immunology.

[33]  C. Dinarello,et al.  Immunological and inflammatory functions of the interleukin-1 family. , 2009, Annual review of immunology.

[34]  M. Behr,et al.  NOD2-Deficient Mice Have Impaired Resistance to Mycobacterium tuberculosis Infection through Defective Innate and Adaptive Immunity1 , 2008, The Journal of Immunology.

[35]  J. Musser,et al.  Identification of Mycobacterium tuberculosis Clinical Isolates with Altered Phagocytosis by Human Macrophages Due to a Truncated Lipoarabinomannan* , 2008, Journal of Biological Chemistry.

[36]  P. Méndez-Samperio Expression and regulation of chemokines in mycobacterial infection. , 2008, The Journal of infection.

[37]  D. Flaherty,et al.  Interleukin-10 Promotes Mycobacterium tuberculosis Disease Progression in CBA/J Mice1 , 2008, The Journal of Immunology.

[38]  S. Yamasaki,et al.  Mincle is an ITAM-coupled activating receptor that senses damaged cells , 2008, Nature Immunology.

[39]  A. Mantovani,et al.  Role of the chemokine decoy receptor D6 in balancing inflammation, immune activation, and antimicrobial resistance in Mycobacterium tuberculosis infection , 2008, The Journal of experimental medicine.

[40]  Z. Sever-Chroneos,et al.  An antibody against the surfactant protein A (SP‐A)‐binding domain of the SP‐A receptor inhibits T cell‐mediated immune responses to Mycobacterium tuberculosis , 2008, Journal of leukocyte biology.

[41]  A. Azad,et al.  Pulmonary surfactant protein A regulates TLR expression and activity in human macrophages. , 2008, Journal of immunology.

[42]  E. Graviss,et al.  Common nonsynonymous polymorphisms in the NOD2 gene are associated with resistance or susceptibility to tuberculosis disease in African Americans. , 2008, The Journal of infectious diseases.

[43]  J. Ruland,et al.  Decreased Pathology and Prolonged Survival of Human DC-SIGN Transgenic Mice during Mycobacterial Infection1 , 2008, The Journal of Immunology.

[44]  T. van der Poll,et al.  The mannose cap of mycobacterial lipoarabinomannan does not dominate the Mycobacterium–host interaction , 2008, Cellular microbiology.

[45]  S. Kaufmann,et al.  Handbook of Tuberculosis , 2008 .

[46]  S. Khader,et al.  IL-23 and IL-17 in tuberculosis. , 2008, Cytokine.

[47]  A. Azad,et al.  Role of C-type lectins in mycobacterial infections. , 2008, Current drug targets.

[48]  Grace Y Chen,et al.  Intracellular NOD‐like receptors in innate immunity, infection and disease , 2007, Cellular microbiology.

[49]  K. Boyd,et al.  The inhibitory cytokine IL-35 contributes to regulatory T-cell function , 2007, Nature.

[50]  S. Gandotra,et al.  Nucleotide-Binding Oligomerization Domain Protein 2-Deficient Mice Control Infection with Mycobacterium tuberculosis , 2007, Infection and Immunity.

[51]  L. Settas,et al.  Reactivation of pulmonary tuberculosis in a patient with rheumatoid arthritis during treatment with IL-1 receptor antagonists (anakinra). , 2007, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[52]  S. Khader,et al.  Interleukin-12 and tuberculosis: an old story revisited. , 2007, Current opinion in immunology.

[53]  B. Ryffel,et al.  IL-1 Receptor-Mediated Signal Is an Essential Component of MyD88-Dependent Innate Response to Mycobacterium tuberculosis Infection , 2007, The Journal of Immunology.

[54]  Xujian Li,et al.  IFN-γ Acts Directly on Activated CD4+ T Cells during Mycobacterial Infection to Promote Apoptosis by Inducing Components of the Intracellular Apoptosis Machinery and by Inducing Extracellular Proapoptotic Signals1 , 2007, The Journal of Immunology.

[55]  Chul Hee Choi,et al.  Intracellular signalling cascades regulating innate immune responses to Mycobacteria: branching out from Toll‐like receptors , 2007, Cellular microbiology.

[56]  R. Locksley,et al.  IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge , 2007, Nature Immunology.

[57]  S. Nakae,et al.  IL-17-Mediated Regulation of Innate and Acquired Immune Response against Pulmonary Mycobacterium bovis Bacille Calmette-Guérin Infection1 , 2007, The Journal of Immunology.

[58]  W. Britton,et al.  Life and death in the granuloma: immunopathology of tuberculosis , 2007, Immunology and cell biology.

[59]  T. van der Poll,et al.  Mice lacking SIGNR1 have stronger T helper 1 responses to Mycobacterium tuberculosis. , 2007, Microbes and infection.

[60]  David G. Russell,et al.  Who puts the tubercle in tuberculosis? , 2007, Nature Reviews Microbiology.

[61]  W. Britton,et al.  Interleukin-23 Restores Immunity to Mycobacterium tuberculosis Infection in IL-12p40-Deficient Mice and Is Not Required for the Development of IL-17-Secreting T Cell Responses1 , 2006, The Journal of Immunology.

[62]  M. Yadav,et al.  The beta-glucan receptor dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria. , 2006, Blood.

[63]  L. Zhao,et al.  A polymorphism in Toll-interleukin 1 receptor domain containing adaptor protein is associated with susceptibility to meningeal tuberculosis. , 2006, The Journal of infectious diseases.

[64]  Jennifer L. Martin,et al.  Surfactant Protein D Increases Fusion of Mycobacterium tuberculosis- Containing Phagosomes with Lysosomes in Human Macrophages , 2006, Infection and Immunity.

[65]  J. Flynn,et al.  IL-17 Production Is Dominated by γδ T Cells rather than CD4 T Cells during Mycobacterium tuberculosis Infection1 , 2006, The Journal of Immunology.

[66]  N. Klein,et al.  Mannose‐binding lectin in innate immunity: past, present and future , 2006, Tissue antigens.

[67]  A. Azad,et al.  Fine Discrimination in the Recognition of Individual Species of Phosphatidyl-myo-Inositol Mannosides from Mycobacterium tuberculosis by C-Type Lectin Pattern Recognition Receptors1 , 2006, The Journal of Immunology.

[68]  L. Joosten,et al.  Mycobacterium tuberculosis Induces Interleukin-32 Production through a Caspase- 1/IL-18/Interferon-γ-Dependent Mechanism , 2006, PLoS medicine.

[69]  Maureen E. Taylor,et al.  Widely Divergent Biochemical Properties of the Complete Set of Mouse DC-SIGN-related Proteins* , 2006, Journal of Biological Chemistry.

[70]  R. Hernández-Pando,et al.  A combination of a transforming growth factor‐β antagonist and an inhibitor of cyclooxygenase is an effective treatment for murine pulmonary tuberculosis , 2006, Clinical and experimental immunology.

[71]  J. Anaya,et al.  Analysis of IL1B, TAP1, TAP2 and IKBL polymorphisms on susceptibility to tuberculosis. , 2006, Tissue antigens.

[72]  J. Flynn,et al.  Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension , 2006, Cellular microbiology.

[73]  S. Kaufmann,et al.  New insights into the function of granulomas in human tuberculosis , 2006, The Journal of pathology.

[74]  P. Conti,et al.  Interleukin -1beta (IL-1 beta), interleukin 6 (IL-6) and tumor necrosis factor (TNF) in plasma and pleural fluid of pneumonia, lung cancer and tuberculous pleuritis. , 2006, Journal of biological regulators and homeostatic agents.

[75]  J. Flynn,et al.  IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. , 2006, Journal of immunology.

[76]  M. Selman,et al.  A functional promoter polymorphism in monocyte chemoattractant protein–1 is associated with increased susceptibility to pulmonary tuberculosis , 2005, The Journal of experimental medicine.

[77]  M. Netea,et al.  NOD2 and Toll-Like Receptors Are Nonredundant Recognition Systems of Mycobacterium tuberculosis , 2005, PLoS pathogens.

[78]  A. Azad,et al.  The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis , 2005, The Journal of experimental medicine.

[79]  Alimuddin Zumla,et al.  Lung remodeling in pulmonary tuberculosis. , 2005, The Journal of infectious diseases.

[80]  C. Mason,et al.  Pulmonary Interleukin-23 Gene Delivery Increases Local T-Cell Immunity and Controls Growth of Mycobacterium tuberculosis in the Lungs , 2005, Infection and Immunity.

[81]  K. Natarajan,et al.  Regulation of immune responses to Mycobacterium tuberculosis secretory antigens by dendritic cells. , 2005, Tuberculosis.

[82]  S. Khader,et al.  IL-23 Compensates for the Absence of IL-12p70 and Is Essential for the IL-17 Response during Tuberculosis but Is Dispensable for Protection and Antigen-Specific IFN-γ Responses if IL-12p70 Is Available1 , 2005, The Journal of Immunology.

[83]  C. Hunter New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions , 2005, Nature Reviews Immunology.

[84]  S. Kaufmann,et al.  Differential organization of the local immune response in patients with active cavitary tuberculosis or with nonprogressive tuberculoma. , 2005, The Journal of infectious diseases.

[85]  Mahavir Singh,et al.  Mycobacterium Tuberculosis Heat Shock Proteins Use Diverse Toll-like Receptor Pathways to Activate Pro-inflammatory Signals* , 2005, Journal of Biological Chemistry.

[86]  Z. Toossi,et al.  Bioactivation of Latent Transforming Growth Factor β1 by Mycobacterium tuberculosis in Human Mononuclear Phagocytes , 2005, Scandinavian journal of immunology.

[87]  Alberto Mantovani,et al.  Increased inflammation in mice deficient for the chemokine decoy receptor D6 , 2005, European journal of immunology.

[88]  T. Mak,et al.  The IL-27 Receptor Chain WSX-1 Differentially Regulates Antibacterial Immunity and Survival during Experimental Tuberculosis 1 , 2005, The Journal of Immunology.

[89]  John Chan,et al.  What's good for the host is good for the bug. , 2005, Trends in microbiology.

[90]  I. Maridonneau-Parini,et al.  Mycobacteria use their surface-exposed glycolipids to infect human macrophages through a receptor-dependent process Published, JLR Papers in Press, December 1, 2004. DOI 10.1194/jlr.M400308-JLR200 , 2005, Journal of Lipid Research.

[91]  S. Gordon,et al.  Ligand recognition by antigen-presenting cell C-type lectin receptors , 2004, Current Opinion in Immunology.

[92]  M. Fenton,et al.  Receptor-Mediated Recognition of Mycobacterium tuberculosis by Host Cells , 2005 .

[93]  J. Wright Immunoregulatory functions of surfactant proteins , 2005, Nature Reviews Immunology.

[94]  Shin-Il Kim,et al.  Mycobacterial granulomas: keys to a long-lasting host-pathogen relationship. , 2004, Clinical immunology.

[95]  S. Kaufmann,et al.  Human tuberculous granulomas induce peripheral lymphoid follicle‐like structures to orchestrate local host defence in the lung , 2004, The Journal of pathology.

[96]  V. García,et al.  IL‐10 down‐regulates costimulatory molecules on Mycobacterium tuberculosis‐pulsed macrophages and impairs the lytic activity of CD4 and CD8 CTL in tuberculosis patients , 2004, Clinical and experimental immunology.

[97]  I. Orme,et al.  Gamma Interferon Production by Bovine γδ T Cells following Stimulation with Mycobacterial Mycolylarabinogalactan Peptidoglycan , 2004, Infection and Immunity.

[98]  John Chan,et al.  TNF Influences Chemokine Expression of Macrophages In Vitro and That of CD11b+ Cells In Vivo during Mycobacterium tuberculosis Infection1 , 2004, The Journal of Immunology.

[99]  Jennifer L. Martin,et al.  Complement Protein C3 Binding to Mycobacterium tuberculosis Is Initiated by the Classical Pathway in Human Bronchoalveolar Lavage Fluid , 2004, Infection and Immunity.

[100]  M. Behr Tuberculosis due to multiple strains: a concern for the patient? A concern for tuberculosis control? , 2004, American journal of respiratory and critical care medicine.

[101]  L. Kremer,et al.  Toll-Like Receptor 2 (TLR2)-Dependent-Positive and TLR2-Independent-Negative Regulation of Proinflammatory Cytokines by Mycobacterial Lipomannans , 2004 .

[102]  I. Orme,et al.  Gamma interferon production by bovine gamma delta T cells following stimulation with mycobacterial mycolylarabinogalactan peptidoglycan. , 2004, Infection and immunity.

[103]  B. Ryffel,et al.  Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection. , 2004, The American journal of pathology.

[104]  G. Kaplan,et al.  Mycobacterium tuberculosis Growth at theCavity Surface: a Microenvironment with FailedImmunity , 2003, Infection and Immunity.

[105]  P. Allavena,et al.  Cross-Linking of the Mannose Receptor on Monocyte-Derived Dendritic Cells Activates an Anti-Inflammatory Immunosuppressive Program 1 , 2003, The Journal of Immunology.

[106]  G. Trinchieri,et al.  The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. , 2003, Immunity.

[107]  C. Garlanda,et al.  Unique pattern of expression and inhibition of IL-1 signaling by the IL-1 receptor family member TIR8/SIGIRR. , 2003, European cytokine network.

[108]  V. Quesniaux,et al.  Control of Mycobacterium bovis BCG infection with increased inflammation in TLR4-deficient mice. , 2003, Microbes and infection.

[109]  JoAnne L. Flynn,et al.  Experimental Mycobacterium tuberculosis Infection of Cynomolgus Macaques Closely Resembles the Various Manifestations of Human M. tuberculosis Infection , 2003, Infection and Immunity.

[110]  P. Méndez-Samperio,et al.  Infection of human monocytes with Mycobacterium bovis BCG induces production of CC-chemokines. , 2003, The Journal of infection.

[111]  M. Roncarolo,et al.  IL-10 and TGF-beta induce alloreactive CD4+CD25- T cells to acquire regulatory cell function. , 2003, Blood.

[112]  J. Casanova,et al.  Mini‐review The role of interleukin‐12 in human infectious diseases: only a faint signature , 2003, European journal of immunology.

[113]  A. Foussat,et al.  Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10. , 2003, Blood.

[114]  T. Geijtenbeek,et al.  Mycobacteria Target DC-SIGN to Suppress Dendritic Cell Function , 2003, The Journal of experimental medicine.

[115]  R. Coffman,et al.  Transgenic Mice Expressing Human Interleukin-10 in the Antigen-Presenting Cell Compartment Show Increased Susceptibility to Infection with Mycobacterium avium Associated with Decreased Macrophage Effector Function and Apoptosis , 2002, Infection and Immunity.

[116]  I. Orme,et al.  In Vivo IL-10 Production Reactivates Chronic Pulmonary Tuberculosis in C57BL/6 Mice1 , 2002, The Journal of Immunology.

[117]  Yasunori Ogura,et al.  Induction of Nod2 in Myelomonocytic and Intestinal Epithelial Cells via Nuclear Factor-κB Activation* , 2002, The Journal of Biological Chemistry.

[118]  S. Behar,et al.  Activation of NKT Cells Protects Mice from Tuberculosis , 2002, Infection and Immunity.

[119]  D. Voelker,et al.  Pulmonary Surfactant Protein A Up-Regulates Activity of the Mannose Receptor, a Pattern Recognition Receptor Expressed on Human Macrophages1 , 2002, The Journal of Immunology.

[120]  E. Coccia,et al.  Selective Expression of Type I IFN Genes in Human Dendritic Cells Infected with Mycobacterium tuberculosis1 , 2002, The Journal of Immunology.

[121]  N. Boéchat,et al.  Alpha/Beta Interferon Impairs the Ability of Human Macrophages To Control Growth of Mycobacterium bovis BCG , 2002, Infection and Immunity.

[122]  J. Schorey,et al.  Differential Regulation of the Mitogen-Activated Protein Kinases by Pathogenic and Nonpathogenic Mycobacteria , 2002, Infection and Immunity.

[123]  E. Raz,et al.  IFN-αβ Promote Priming of Antigen-Specific CD8+ and CD4+ T Lymphocytes by Immunostimulatory DNA-Based Vaccines1 , 2002, The Journal of Immunology.

[124]  Andrew G. D. Bean,et al.  TNF Regulates Chemokine Induction Essential for Cell Recruitment, Granuloma Formation, and Clearance of Mycobacterial Infection1 , 2002, The Journal of Immunology.

[125]  K. Hughes,et al.  FimZ Is a Molecular Link between Sticking and Swimming in Salmonella enterica Serovar Typhimurium , 2002, Journal of bacteriology.

[126]  S. Akira,et al.  [Induction of direct antimicrobial activity through mammalian toll-like receptors]. , 2001, Pneumologie.

[127]  E. Raz,et al.  IFN-alpha beta promote priming of antigen-specific CD8+ and CD4+ T lymphocytes by immunostimulatory DNA-based vaccines. , 2002, Journal of immunology.

[128]  P. Sonnenberg,et al.  HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers , 2001, The Lancet.

[129]  S. Mizuno,et al.  Role of Interleukin (IL)‐1 Type 1 Receptor in Mycobacterial Infection , 2001, Microbiology and immunology.

[130]  M. Fenton,et al.  Differential roles of Toll-like receptors in the elicitation of proinflammatory responses by macrophages , 2001, Annals of the rheumatic diseases.

[131]  E. Chan,et al.  What is the role of nitric oxide in murine and human host defense against tuberculosis?Current knowledge. , 2001, American journal of respiratory cell and molecular biology.

[132]  R. Steinman,et al.  Five mouse homologues of the human dendritic cell C-type lectin, DC-SIGN. , 2001, International immunology.

[133]  S. Ehlers,et al.  Inflammation and lymphocyte activation during mycobacterial infection in the interferon-gamma-deficient mouse. , 2001, Cellular immunology.

[134]  Capucine Picard,et al.  Impaired Interferon Gamma-Mediated Immunity and Susceptibility to Mycobacterial Infection in Childhood , 2001, Pediatric Research.

[135]  G. Puzo,et al.  Mannosylated Lipoarabinomannans Inhibit IL-12 Production by Human Dendritic Cells: Evidence for a Negative Signal Delivered Through the Mannose Receptor1 , 2001, The Journal of Immunology.

[136]  H. Arai,et al.  Distinct Signaling Pathways for MCP-1-dependent Integrin Activation and Chemotaxis* , 2001, The Journal of Biological Chemistry.

[137]  G. Kaplan,et al.  Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[138]  I. Orme,et al.  The progression of chronic tuberculosis in the mouse does not require the participation of B lymphocytes or interleukin-4 , 2001, Experimental Gerontology.

[139]  S. Yamaoka,et al.  Nod2, a Nod1/Apaf-1 Family Member That Is Restricted to Monocytes and Activates NF-κB* , 2001, The Journal of Biological Chemistry.

[140]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[141]  S. Gordon,et al.  Binding properties of the mannose receptor. , 2001, Immunobiology.

[142]  J. Keane,et al.  Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. , 2001, The New England journal of medicine.

[143]  J Wagner,et al.  Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. , 2000, Immunity.

[144]  T. van der Poll,et al.  Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis. , 2000, The Journal of infectious diseases.

[145]  Juha Saharinen,et al.  Specific Sequence Motif of 8-Cys Repeats of TGF-β Binding Proteins, LTBPs, Creates a Hydrophobic Interaction Surface for Binding of Small Latent TGF-β , 2000 .

[146]  B. Saunders,et al.  Restraining mycobacteria: Role of granulomas in mycobacterial infections , 2000, Immunology and cell biology.

[147]  Y. Iwakura,et al.  Protective Role of Interleukin-1 in Mycobacterial Infection in IL-1 α/β Double-Knockout Mice , 2000, Laboratory Investigation.

[148]  V. Boussiotis,et al.  IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. , 2000, The Journal of clinical investigation.

[149]  C. Figdor,et al.  Identification of DC-SIGN, a Novel Dendritic Cell–Specific ICAM-3 Receptor that Supports Primary Immune Responses , 2000, Cell.

[150]  B. Ryffel,et al.  Fatal Mycobacterium bovis BCG infection in TNF-LT-α-deficient mice , 2000 .

[151]  P. Salgame,et al.  Mycobacterium tuberculosisInfection in Complement Receptor 3-Deficient Mice , 2000 .

[152]  Y. Iwakura,et al.  Protective role of interleukin-1 in mycobacterial infection in IL-1 alpha/beta double-knockout mice. , 2000, Laboratory investigation; a journal of technical methods and pathology.

[153]  J. Keski‐Oja,et al.  Specific sequence motif of 8-Cys repeats of TGF-beta binding proteins, LTBPs, creates a hydrophobic interaction surface for binding of small latent TGF-beta. , 2000, Molecular biology of the cell.

[154]  B. Ryffel,et al.  Fatal Mycobacterium bovis BCG infection in TNF-LT-alpha-deficient mice. , 2000, Clinical immunology.

[155]  A. Aderem,et al.  Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[156]  W. Knapp,et al.  TGF-β1 regulation of dendritic cells , 1999 .

[157]  M. Mayo,et al.  Interleukin-10 Signaling Blocks Inhibitor of κB Kinase Activity and Nuclear Factor κB DNA Binding* , 1999, The Journal of Biological Chemistry.

[158]  Saunders,et al.  Granuloma formation is required to contain bacillus growth and delay mortality in mice chronically infected with Mycobacterium tuberculosis , 1999, Immunology.

[159]  A. Yoshimura,et al.  Interleukin-10 (IL-10) selectively enhances CIS3/SOCS3 mRNA expression in human neutrophils: evidence for an IL-10-induced pathway that is independent of STAT protein activation. , 1999, Blood.

[160]  F. Ruscetti,et al.  Induction of CD4+ T cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-beta. , 1999, Journal of immunology.

[161]  T. van der Poll,et al.  Elevated Chemokine Concentrations in Sera of Human Immunodeficiency Virus (HIV)-Seropositive and HIV-Seronegative Patients with Tuberculosis: a Possible Role for Mycobacterial Lipoarabinomannan , 1999, Infection and Immunity.

[162]  D. Voelker,et al.  Surfactant Protein D Binds to Mycobacterium tuberculosis Bacilli and Lipoarabinomannan via Carbohydrate-Lectin Interactions Resulting in Reduced Phagocytosis of the Bacteria by Macrophages1 , 1999, The Journal of Immunology.

[163]  S. Akira,et al.  Role of Interleukin-18 (IL-18) in Mycobacterial Infection in IL-18-Gene-Disrupted Mice , 1999, Infection and Immunity.

[164]  C. Mody,et al.  Interleukin-8 induces lymphocyte chemotaxis into the pleural space. Role of pleural macrophages. , 1999, American journal of respiratory and critical care medicine.

[165]  T. Udagawa,et al.  Role of tumor necrosis factor-alpha in Mycobacterium-induced granuloma formation in tumor necrosis factor-alpha-deficient mice. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[166]  J. Wang,et al.  Macrophages are a significant source of type 1 cytokines during mycobacterial infection. , 1999, The Journal of clinical investigation.

[167]  J. Sedgwick,et al.  Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. , 1999, Journal of immunology.

[168]  I. Maridonneau-Parini,et al.  The Mannose Receptor Mediates Uptake of Pathogenic and Nonpathogenic Mycobacteria and Bypasses Bactericidal Responses in Human Macrophages , 1999, Infection and Immunity.

[169]  S. Giosué,et al.  Cytokine levels correlate with a radiologic score in active pulmonary tuberculosis. , 1999, American journal of respiratory and critical care medicine.

[170]  D. Voelker,et al.  Surfactant protein D binds to Mycobacterium tuberculosis bacilli and lipoarabinomannan via carbohydrate-lectin interactions resulting in reduced phagocytosis of the bacteria by macrophages. , 1999, Journal of immunology.

[171]  W. Knapp,et al.  TGF-beta1 regulation of dendritic cells. , 1999, Microbes and infection.

[172]  M. Mayo,et al.  Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding. , 1999, The Journal of biological chemistry.

[173]  K. Chang,et al.  Increased TNF-alpha, IL-1 beta and IL-6 levels in the bronchoalveolar lavage fluid with the upregulation of their mRNA in macrophages lavaged from patients with active pulmonary tuberculosis. , 1999, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[174]  K. Murphy,et al.  Low Dose TGF-β Attenuates IL-12 Responsiveness in Murine Th Cells , 1998, The Journal of Immunology.

[175]  S. Sriram,et al.  TGF-beta inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes. , 1998, Journal of immunology.

[176]  R. North Mice incapable of making IL‐4 or IL‐10 display normal resistance to infection with Mycobacterium tuberculosis , 1998, Clinical and experimental immunology.

[177]  G. Trinchieri,et al.  Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10. , 1998, Journal of immunology.

[178]  J. Casanova,et al.  Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. , 1998, Science.

[179]  K. Murphy,et al.  Low dose TGF-beta attenuates IL-12 responsiveness in murine Th cells. , 1998, Journal of immunology.

[180]  J. Ellner,et al.  Role of CR4 in Mycobacterium tuberculosis-human macrophages binding and signal transduction in the absence of serum. , 1998, Infection and immunity.

[181]  M. Burdick,et al.  Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis , 1997, Infection and immunity.

[182]  S. Kaufmann,et al.  Lethal tuberculosis in interleukin-6-deficient mutant mice , 1997, Infection and immunity.

[183]  C. Heldin,et al.  Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling , 1997, Nature.

[184]  I. Orme,et al.  Interleukin 12 (IL-12) Is Crucial to the Development of Protective Immunity in Mice Intravenously Infected with Mycobacterium tuberculosis , 1997, The Journal of experimental medicine.

[185]  T. Byrd Tumor necrosis factor alpha (TNFalpha) promotes growth of virulent Mycobacterium tuberculosis in human monocytes iron-mediated growth suppression is correlated with decreased release of TNFalpha from iron-treated infected monocytes. , 1997, The Journal of clinical investigation.

[186]  N. Mukaida,et al.  Elevated chemokine levels in bronchoalveolar lavage fluid of tuberculosis patients. , 1997, American journal of respiratory and critical care medicine.

[187]  R. Ransohoff,et al.  TGF-beta suppresses IFN-gamma induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression. , 1997, Journal of immunology.

[188]  C. Heldin,et al.  Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. , 1997, Nature.

[189]  R. Young,et al.  T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. , 1997, Journal of immunology.

[190]  U. Boehm,et al.  Cellular responses to interferon-gamma. , 1997, Annual review of immunology.

[191]  T. Walsh,et al.  IL-10 exerts suppressive and enhancing effects on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. , 1997, Journal of immunology.

[192]  J. Ernst,et al.  Selective receptor blockade during phagocytosis does not alter the survival and growth of Mycobacterium tuberculosis in human macrophages. , 1996, American journal of respiratory cell and molecular biology.

[193]  T. Molitor,et al.  Differential infection of porcine alveolar macrophage subpopulations by nonopsonized Mycobacterium bovis involves CD14 receptors , 1996, Journal of leukocyte biology.

[194]  P. Barnes,et al.  Absence of a prominent Th2 cytokine response in human tuberculosis , 1996, Infection and immunity.

[195]  H. Niiro,et al.  Suppression of superoxide anion production by interleukin-10 is accompanied by a downregulation of the genes for subunit proteins of NADPH oxidase. , 1996, Experimental hematology.

[196]  P. Tassone,et al.  IL-10 inhibits nuclear factor-kappa B/Rel nuclear activity in CD3-stimulated human peripheral T lymphocytes. , 1996, Journal of immunology.

[197]  J. Flynn,et al.  IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. , 1995, Journal of immunology.

[198]  J. Abrams,et al.  T-cell cytokine responses in human infection with Mycobacterium tuberculosis , 1995, Infection and immunity.

[199]  C. Lowenstein,et al.  Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. , 1995, Immunity.

[200]  Peng Wang,et al.  Interleukin (IL)-10 Inhibits Nuclear Factor B (NFB) Activation in Human Monocytes , 1995, The Journal of Biological Chemistry.

[201]  Alan D. Roberts,et al.  The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. , 1995, Immunology.

[202]  M. Billah,et al.  Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. , 1995, The Journal of biological chemistry.

[203]  H. Shiratsuchi,et al.  Enhanced production of TGF-beta by blood monocytes from patients with active tuberculosis and presence of TGF-beta in tuberculous granulomatous lung lesions. , 1995, Journal of immunology.

[204]  E. Ruoslahti,et al.  Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. , 1994, The Biochemical journal.

[205]  L. Schlesinger,et al.  Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages. , 1994, Journal of immunology.

[206]  T. Gerrard,et al.  Macrophage-colony-stimulating factor expression by anti-CD45 stimulated human monocytes is transcriptionally up-regulated by IL-1 beta and inhibited by IL-4 and IL-10. , 1994, Journal of immunology.

[207]  J. Ellner,et al.  Complement receptor-mediated uptake and tumor necrosis factor-alpha-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. , 1994, Journal of immunology.

[208]  R. Appelberg Protective role of interferon gamma, tumor necrosis factor alpha and interleukin-6 in Mycobacterium tuberculosis and M. avium infections. , 1994, Immunobiology.

[209]  J. Flynn,et al.  An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection , 1993, The Journal of experimental medicine.

[210]  C. Figdor,et al.  Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. , 1993, Journal of immunology.

[211]  I. Orme,et al.  Disseminated tuberculosis in interferon gamma gene-disrupted mice , 1993, The Journal of experimental medicine.

[212]  A. Sher,et al.  Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[213]  G. Trinchieri,et al.  Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma- production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells , 1993, The Journal of experimental medicine.

[214]  P. Nibbering,et al.  Interleukin-8 enhances nonoxidative intracellular killing of Mycobacterium fortuitum by human granulocytes , 1993, Infection and immunity.

[215]  P. Puccetti,et al.  Interleukin‐4 and interleukin‐10 inhibit nitric oxide‐dependent macrophage killing of Candida albicans , 1993, European journal of immunology.

[216]  K. Decker [Tumor necrosis factor alpha]. , 1992, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis.

[217]  J. Abrams,et al.  Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure. , 1992, Journal of immunology.

[218]  A. Sher,et al.  IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity. , 1992, Journal of immunology.

[219]  S. Moncada,et al.  Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages. , 1992, Biochemical and biophysical research communications.

[220]  H. Niiro,et al.  Epstein-Barr virus BCRF1 gene product (viral interleukin 10) inhibits superoxide anion production by human monocytes. , 1992, Lymphokine and cytokine research.

[221]  R. Coffman,et al.  Regulation of immunity to parasites by T cells and T cell-derived cytokines. , 1992, Annual review of immunology.

[222]  T. Mosmann,et al.  IL-10 inhibits cytokine production by activated macrophages. , 1991, Journal of immunology.

[223]  Y. Vodovotz,et al.  Macrophage deactivation by interleukin 10 , 1991, The Journal of experimental medicine.

[224]  S. Lowry,et al.  Tumor necrosis factor-α , 1991 .

[225]  C G Figdor,et al.  Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes , 1991, The Journal of experimental medicine.

[226]  Horsburgh Cr Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. , 1991, The New England journal of medicine.

[227]  C. Horsburgh Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. , 1991, The New England journal of medicine.

[228]  M. Horwitz,et al.  Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. , 1990, Journal of immunology.

[229]  G. Broquié [Tuberculosis infection]. , 1927, Soins; la revue de reference infirmiere.